ITPRIP and Alzheimer disease: Located near a previously reported AD linkage peak [57], ITPRIP is an attractive AD candidate therapeutic target because of its role in cell death; it binds and inhibits the activity of death-associated protein kinase, a key component in cell death signaling pathways [58].